Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

At PSA, Meet The New Deal-Makers (Part 1)

This article was originally published in The Pink Sheet Daily

Executive Summary

Two of the biopharma industry's newest heads of business development talked with Elsevier Business Intelligence Editor-in-Chief Chris Morrison at the Pharmaceutical Strategic Alliances conference on Sept. 22 in New York.
Advertisement

Related Content

AstraZeneca Hit By U.S. Generic Competition In 2010; Extends Share Buyback Program
AstraZeneca Hit By U.S. Generic Competition In 2010; Extends Share Buyback Program
At PSA, Meet The New Deal-Makers (Part 2)
At PSA, Meet The New Deal-Makers (Part 2)
AstraZeneca Names A New Head Of Business Development & Licensing
AstraZeneca Names A New Head Of Business Development & Licensing
Big Pharmas Come Together On TB, But Effort To Accelerate Development May Hit Speedbump From Lack Of Biomarkers
AstraZeneca Pares R&D Areas By 25 Percent, But Will Continue Licensing

Topics

Advertisement
UsernamePublicRestriction

Register

PS071262

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel